THe FINANCIAL — Eli Lilly and Company (NYSE: LLY) announced a definitive agreement to acquire Disarm Therapeutics, a privately-held biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration. Disarm has discovered novel, potent SARM1 inhibitors and is advancing
More
The FINANCIAL — AstraZeneca’s Forxiga (dapagliflozin) has been recommended for an indication extension of its marketing authorisation in the European Union (EU) for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF) in adults with and without type-2 diabetes (T2D). Heart
More
The FINANCIAL — Roche today announced that the US Food and Drug Administration (FDA) has granted full approval of Venclexta® (venetoclax) in combination with azacitidine, or decitabine, or low-dose cytarabine (LDAC) for the treatment of newly diagnosed acute myeloid leukaemia (AML) in adults
More
The FINANCIAL — AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been recommended for marketing authorisation in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of
More
The FINANCIAL — Despite the challenges posed by Covid-19, Bayer confirms significant progress on its sustainability commitments / Highly innovative carbon initiatives are redefining the value of farming by rewarding farmers for generating carbon credits when adopting climate-smart practices / Game-changing launch
More
The FINANCIAL — Insecure, illicit, infectious—three I’s no one wants near their eyes, which is why the AOA is issuing a Halloween warning against illegally sold contact lenses and urging doctors to report such retailers. As Americans still grapple with an ongoing
More
The FINANCIAL — Takeda Pharmaceutical Company Limited, Accenture and Amazon Web Services (AWS) have entered into a five-year strategic agreement to accelerate Takeda’s digital transformation. Not only will patients benefit from Takeda’s ability to respond with greater speed, agility, and insights across the
More
The FINANCIAL — Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on behalf of the European Union (EU) Member States, has approved an Advance Purchase Agreement in which the Janssen Pharmaceutical Companies will supply 200 million
More
The FINANCIAL — AOA and optometry’s advocates continue to fight the FTC’s rule changes—act now to support these efforts and have your practice ready for implementation on day one. As optometry’s advocates work into the 11th hour to counter the Federal Trade
More
The FINANCIAL -- Abbott this days announced the launch of a new, smarter heart monitor for better arrhythmia detection—positive news for people at risk for irregular heartbeats.
More